Litcius/Paper detail

Olverembatinib: First Approval

Sohita Dhillon

2022Drugs64 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDasatinibImatinibGiSTTyrosine-kinase inhibitorPhiladelphia chromosomeTyrosine kinaseCancer researchMyeloid leukemiaOncologyInternal medicinePharmacologyStromal cellCancerChromosomal translocationBiologyBiochemistryReceptorGeneChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research
Olverembatinib: First Approval | Litcius